Literature DB >> 1965334

Use of a sialic acid analogue to analyze the importance of the receptor-destroying enzyme for the interaction of influenza C virus with cells.

G Herrler1, H J Gross, G Milks, J C Paulson, H D Klenk, R Brossmer.   

Abstract

Influenza C virus uses 9-O-acetyl-N-acetylaneuraminic acid (9-O-acetyl-Neu5Ac) as a receptor determinant for attachment to cells. The virus contains an acetylesterase which releases acetyl residues from position C-9 of sialic acid thereby inactivating the receptors. A synthetic sialic acid analogue, 9-N-acetyl-Neu5Ac, was attached to cell surface glycoconjugates by purified sialyltransferase and analyzed for its ability to substitute the 9-O-acetylated sialic acid. Erythrocytes which have been modified to contain either 9-O-acetyl-Neu5Ac or 9-N-acetyl-Neu5Ac were agglutinated by influenza C virus to the same titer. However, in contrast to the 9-O-acetyl group the 9-N-acetyl residue is resistant to cleavage by the viral acetylesterase. This characteristic property (recognition as a receptor determinant by influenza C virus, but resistance against the action of the receptor-destroying enzyme) makes this synthetic analogue a valuable tool to analyze the role of the receptor-destroying enzyme for an influenza C virus infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965334

Source DB:  PubMed          Journal:  Acta Histochem Suppl        ISSN: 0567-7556


  6 in total

1.  Initial events in infectious salmon anemia virus infection: evidence for the requirement of a low-pH step.

Authors:  T M Eliassen; M K Frøystad; B H Dannevig; M Jankowska; A Brech; K Falk; K Romøren; T Gjøen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.

Authors:  Mohit P Mathew; Elaine Tan; Jason W Labonte; Shivam Shah; Christopher T Saeui; Lingshu Liu; Rahul Bhattacharya; Patawut Bovonratwet; Jeffrey J Gray; Kevin J Yarema
Journal:  Chembiochem       Date:  2017-04-20       Impact factor: 3.164

Review 3.  Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Authors:  Haitham A Badr; Dina M M AlSadek; Motawa E El-Houseini; Christopher T Saeui; Mohit P Mathew; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

4.  Exploiting metabolic glycoengineering to advance healthcare.

Authors:  Christian Agatemor; Matthew J Buettner; Ryan Ariss; Keerthana Muthiah; Christopher T Saeui; Kevin J Yarema
Journal:  Nat Rev Chem       Date:  2019-09-06       Impact factor: 34.035

Review 5.  Metabolic glycoengineering: sialic acid and beyond.

Authors:  Jian Du; M Adam Meledeo; Zhiyun Wang; Hargun S Khanna; Venkata D P Paruchuri; Kevin J Yarema
Journal:  Glycobiology       Date:  2009-08-12       Impact factor: 4.313

Review 6.  Host Range, Biology, and Species Specificity of Seven-Segmented Influenza Viruses-A Comparative Review on Influenza C and D.

Authors:  Chithra C Sreenivasan; Zizhang Sheng; Dan Wang; Feng Li
Journal:  Pathogens       Date:  2021-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.